Oncology Imaging Software Market Trends

  • Report ID: 5905
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Oncology Imaging Software Market Trends

Growth Drivers

  • Increasing Demand for Cloud-based Solutions - Picture chronicling and communication frameworks (PACS) play a crucial part in progressed radiology by providing a computerized stage for the potential, recovery, dissemination, and introduction of corrective pictures. A PACS acts as a computer to organize digitized radiological pictures and reports. Further patterns in PACS have transferred absent from standalone structures to enterprise imaging structures that interconnected not as it were radiology but all offices that generate imaging and image-associated reports so they can be concentrated in one area and interconnected into the overarching electronic restorative record (EMR). A few PACS patterns were demonstrated at RSNA23. Chief among them: is cloud-depended PACS. Multiple healthcare suppliers are shifting toward cloud-based PACS dispositions, allowing less requiring entrance to corrective pictures from various areas, promising cooperation among healthcare specialists, and decreasing the need for on-premises cornerstones.
  • Advancement in Technology of Oncology Imaging - A few instrumented progressions like check speed, dual-energy, reciprocating remaking, moo kilovolt, perfusion imaging, and radiation dosage reduction have stressed the clinical utility of CT-based tumor imaging. Correlative imaging has ended up as a basic apparatus in this zone. It comprises various techniques implemented to imagine the human body's insides for clinical assessment and corrective mediation. Inside the setting of oncology, therapeutic imaging acts as a multifaceted part. It assists in early location, when cancer may be most curable, by providing a non-invasive manner to think of tumors. Utilization of planning like X-rays, Computed Tomography (CT) filters, Attractive Reverberation Imaging (MRI), and Positron Outflow Tomography (PET) verifications are habitually implemented to recognize and find tumors, indeed in their beginning stages.
  • Increasing Occurrence of Artificial Intelligence (AI) and Machine Learning (ML) Technologies - The current growth in the area has taken to considerably increased the effectiveness of the technology, which can be utilized to industrialize the gatherings and documentation of date of diagnosis, advancement-free survival, and other cancer-associated tumor characteristics and patient results. Quick-growing imaging creation and explanatory apparatuses enable radiology to act a gradually essential part in cancer screening, resolution arranging, reaction appraisal, and guessing.

Challenges

  • High Disease Pressure of Cancer - Hypertension is more common in patients on anticancer treatment than in the general population as an outcome of numerous mechanisms, comprising direct vascular and renal impacts of anticancer treatment. Hypertension and blood pressure (BP) lability start at the time of commencement of anticancer treatment and remain lifelong, which can outcome in interruptions in therapy and place patients at enhanced risk of cardiovascular disease (CVD) and mortality. Cancer and CVD are major causes of gloominess and mortality internationally. Hypertension is one of the most opportunity agents for the modification of CVD, comprising ischemic heart illness, heart frustration, stroke, and kidney illness. The supremacy of hypertension across the world is extending, coming to 1.3 billion grown-ups in 2019 Despite the accessibility of compelling antihypertensive drugs, BP is insufficiently controlled in nearly 50% of those known to have hypertension.
  • Stringent Government Policies
  • Lack of Knowledge in People about Cancer

Oncology Imaging Software Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

5.9%

Base Year Market Size (2024)

USD 4.24 billion

Forecast Year Market Size (2037)

USD 8.93 billion

Regional Scope

  • North America (North America, Canada, Mexico)
  • Asia Pacific (Japan, China, India, Australia, Others)
  • Europe (Germany, Spain, UK, France, Italy, Russia, Others)
  • Middle East and Africa (South Africa, UAE, Others)
  • Latin America (Brazil, Argentina, Others)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5905
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of oncology imaging software is evaluated at USD 4.44 billion.

The oncology imaging software market size was over USD 4.24 billion in 2024 and is poised to exceed USD 8.93 billion by 2037, witnessing over 5.9% CAGR during the forecast period i.e., between 2025-2037. The increasing prevalence of cancer worldwide will drive the market growth.

North America industry is expected to account for largest revenue share of 41% by 2037, owing to increasing demand for oncology imaging software in this region.

The major players in the market include Pfizer Inc., Business PlanningMain Product OfferingsFinancial ExecutionMain Performance IndicatorsStep-Pharma, Novartis A.G., Abbott, Amgen Inc., Biogen, Johnson & Johnson, Merck & Co., Eli Lilly and Company, Hoffmann-La Roche Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample